Recent evidence suggests that oxytocin signaling and the renin–angiotensin–aldosterone system (RAAS) are closely related to glucose uptake and lipid utilization, whereas dysfunction of oxytocin and the RAAS may lead to ROS imbalance and contribute to the pathogenesis of insulin resistance and dyslipidemia [30,31]. This evidence concerns the gene OXT and metabolic syndrome.